Clinical trial
Exercise to Prevent AnthrCycline-based Cardio-Toxicity Study (EXACT)
NCT02471053 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exercise to Prevent AnthrCycline-based Cardio-Toxicity Study (EXACT)
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- September 30, 2017
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart; disease, functional, inflammation, neoplasms